Gastric Volume in Patients on GLP-1 Medications
NCT05903482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2025-03-19
Summary
Evaluating gastric volume in patients on GLP-1 RA medications
Conditions
Interventions
- OTHER
-
None - observational
Observational
Sponsors & Collaborators
-
Children's Hospital of Philadelphia
lead OTHER
Principal Investigators
-
Elaina Lin, MD · Children's Hospital of Philadelphia
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-06
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- United States
Study Locations
More Related Trials
-
The Effect of Liraglutide on the GIT
NCT04008290 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists
NCT07006142 ·Status: RECRUITING ·Phase: NA
-
The Effects of LAF237 on Gastric Function in Type 2 Diabetes
NCT00952991 ·Status: COMPLETED ·Phase: PHASE3
-
GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
NCT02577848 ·Status: UNKNOWN ·Phase: NA
-
Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans
NCT00876213 ·Status: COMPLETED
-
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
NCT06818292 ·Status: COMPLETED ·Phase: NA
-
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
NCT01509742 ·Status: COMPLETED ·Phase: PHASE1
-
GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans
NCT02731664 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy
NCT05875636 ·Status: COMPLETED
-
Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity
NCT06845033 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality
NCT07127354 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
NCT02042664 ·Status: COMPLETED ·Phase: PHASE3
-
Human Vasodilatory Effect of GLP-1
NCT03502083 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
NCT04034524 ·Status: UNKNOWN
-
Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
NCT00264199 ·Status: COMPLETED ·Phase: NA
-
Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects
NCT03682172 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Plasma GLP1 and Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
NCT02846168 ·Status: UNKNOWN
-
The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion
NCT03018444 ·Status: COMPLETED ·Phase: NA
-
The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects
NCT01579981 ·Status: COMPLETED ·Phase: NA
-
Effects of Gut Peptides on Bone Remodeling
NCT03574064 ·Status: COMPLETED ·Phase: NA
-
The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis
NCT02765399 ·Status: COMPLETED ·Phase: PHASE4
-
GLP-1 and Non-exercise Activity Thermogenesis in RHZ
NCT01638260 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate the Detection of Retained Gastric Contents and Assess Safety Using the Flower Capsule Endoscopy in Healthy Individuals and GLP-1 Receptor Agonist Users
NCT06927401 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
NCT02082496 ·Status: COMPLETED ·Phase: PHASE2